Publication: Orphan designations

First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

Orphan designation: 3-[5-(2-Fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid, for the: Treatment of Duchenne muscular dystrophy

First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Orphan designation: Riociguat, for the: Treatment of systemic sclerosis

First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Orphan designation: Oxytocin, for the: Treatment of Prader-Willi syndrome

First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Orphan designation: Sodium acetate salt of the synthetic peptide H-D-Ala-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-D-Ala-OH, for the: Treatment of necrotising soft tissue infections

First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Orphan designation: Cysteamine bitartrate, for the: Treatment of Huntington’s disease

First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Orphan designation: Marizomib, for the: Treatment of plasma cell myeloma

Entities: myeloma
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Orphan designation: Rilotumumab, for the: Treatment of gastric cancer

Entities: GASTRIC CANCER
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Orphan designation: Recombinant monoclonal antibody to human serum amyloid P component, for the: Treatment of AL amyloidosis

First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Orphan designation: Cediranib, for the: Treatment of ovarian cancer

Quotes

Orphan designation: 5'-O-(trans-9 "-octadecenoyl)-1-ß-D-arabinofuranosyl cytosine, for the: Treatment of acute myeloid leukaemia"

More Content

All (157) | News (0) | Reports (0) | Blogs (157) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Orphan designation: 3-[5-(2-Fluoro-phenyl)-[1,2... [Published Orphan designations - Sep 04 2014]
Orphan designation: Synthetic double-stranded s... [Published Orphan designations - Sep 01 2014]
Orphan designation: Riociguat, for the: Treatme... [Published Orphan designations - Sep 01 2014]
Orphan designation: Synthetic double-stranded s... [Published Orphan designations - Sep 01 2014]
Orphan designation: Recombinant fusion protein ... [Published Orphan designations - Sep 01 2014]
Orphan designation: Oxytocin, for the: Treatmen... [Published Orphan designations - Sep 01 2014]
Orphan designation: Cediranib, for the: Treatme... [Published Orphan designations - Sep 01 2014]
Orphan designation: Recombinant monoclonal anti... [Published Orphan designations - Sep 01 2014]
Orphan designation: Rilotumumab, for the: Treat... [Published Orphan designations - Sep 01 2014]
Orphan designation: Marizomib, for the: Treatme... [Published Orphan designations - Sep 01 2014]
Orphan designation: Cysteamine bitartrate, for ... [Published Orphan designations - Sep 01 2014]
Orphan designation: Humanised recombinant monoc... [Published Orphan designations - Sep 01 2014]
Orphan designation: Sodium acetate salt of the ... [Published Orphan designations - Sep 01 2014]
Orphan designation: Humanised anti-alpha ν... [Published Orphan designations - Sep 01 2014]
Orphan designation: Adeno-associated viral vect... [Published Orphan designations - Sep 01 2014]
Orphan designation: Eculizumab, for the: Treatm... [Published Orphan designations - Sep 01 2014]
Orphan designation: obinutuzumab, for the: Trea... [Published Orphan designations - Aug 22 2014]
Orphan designation: N-carbamyl-L-glutamic acid,... [Published Orphan designations - Jul 25 2014]
Orphan designation: Recombinant human alpha-1-m... [Published Orphan designations - Jul 16 2014]
Orphan designation: Norursodeoxycholic acid, fo... [Published Orphan designations - Jul 16 2014]
Orphan designation: Mixture of two adeno-associ... [Published Orphan designations - Jul 16 2014]
Orphan designation: Mixture of two adeno-associ... [Published Orphan designations - Jul 16 2014]
Orphan designation: Isavuconazonium sulfate, fo... [Published Orphan designations - Jul 16 2014]
Orphan designation: Humanised Fc engineered mon... [Published Orphan designations - Jul 16 2014]
Orphan designation: Beloranib, for the: EU/3/14... [Published Orphan designations - Jul 15 2014]
Orphan designation: Afamelanotide, for the: Tre... [Published Orphan designations - Jul 15 2014]
Orphan designation: Adeno-associated viral vect... [Published Orphan designations - Jul 15 2014]
Orphan designation: Temocillin sodium, for the:... [Published Orphan designations - Jul 14 2014]
Orphan designation: Recombinant human N-acetylg... [Published Orphan designations - Jul 14 2014]
Orphan designation: Recombinant human interleuk... [Published Orphan designations - Jul 14 2014]
1 2 3 4 5 6
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Orphan designation: 3-[5-(2-Fluoro-phenyl)-[1,2... [Published Orphan designations - Sep 04 2014]
Orphan designation: Synthetic double-stranded s... [Published Orphan designations - Sep 01 2014]
Orphan designation: Riociguat, for the: Treatme... [Published Orphan designations - Sep 01 2014]
Orphan designation: Synthetic double-stranded s... [Published Orphan designations - Sep 01 2014]
Orphan designation: Recombinant fusion protein ... [Published Orphan designations - Sep 01 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.